09 July 2019 2 Min Read
WHO leaves key lung cancer drugs off new essential medicines list
They have been used for the treatment of nonsmall cell lung cancer before, but the WHO says more work needs to be done on Keytruda, Opdivo and Tecentriq
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In